Treatment Protocol of Replagal for Patients With Fabry Disease
NCT01031173
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Fabry Disease
Interventions
BIOLOGICAL:
agalsidase alfa
Sponsor
Shire